| Dr Kaiser Shah, MD | |
|
3333 Evergreen Dr Ne, Grand Rapids, MI 49525-9493 | |
| (616) 284-3132 | |
| Not Available |
| Full Name | Dr Kaiser Shah |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 3333 Evergreen Dr Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710305131 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301510705 (Michigan) | Secondary |
| 207L00000X | Anesthesiology | 036147091 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Palos Community Hospital | Palos heights, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwestern Medical Faculty Foundation | 4587576814 | 3255 |
News Archive
Misfiring of the brain's control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.
Hundreds of community members are expected to join AIDS Healthcare Foundation (AHF) at a candlelight vigil and march to mark the 30th anniversary of the discovery of HIV. The "Remember AIDS" event—which will take place on Sunday, June 5th—will begin with a gathering at Matthew Shepard Memorial Park at 7:00 pm.
Inactivation of the MYC-associated factor X gene, MAX, may play a significant role in the development of small-cell lung cancer, scientists believe.
Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).
› Verified 3 days ago
| Entity Name | Northwestern Medical Faculty Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346235314 PECOS PAC ID: 4587576814 Enrollment ID: O20031105000541 |
News Archive
Misfiring of the brain's control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.
Hundreds of community members are expected to join AIDS Healthcare Foundation (AHF) at a candlelight vigil and march to mark the 30th anniversary of the discovery of HIV. The "Remember AIDS" event—which will take place on Sunday, June 5th—will begin with a gathering at Matthew Shepard Memorial Park at 7:00 pm.
Inactivation of the MYC-associated factor X gene, MAX, may play a significant role in the development of small-cell lung cancer, scientists believe.
Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).
› Verified 3 days ago
| Entity Name | Palos Anesthesia Associates, S.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659345791 PECOS PAC ID: 2466485602 Enrollment ID: O20050916000884 |
News Archive
Misfiring of the brain's control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.
Hundreds of community members are expected to join AIDS Healthcare Foundation (AHF) at a candlelight vigil and march to mark the 30th anniversary of the discovery of HIV. The "Remember AIDS" event—which will take place on Sunday, June 5th—will begin with a gathering at Matthew Shepard Memorial Park at 7:00 pm.
Inactivation of the MYC-associated factor X gene, MAX, may play a significant role in the development of small-cell lung cancer, scientists believe.
Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).
› Verified 3 days ago
| Entity Name | Northstar Anesthesia Of Illinois, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962822395 PECOS PAC ID: 4688893878 Enrollment ID: O20140922000405 |
News Archive
Misfiring of the brain's control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.
Hundreds of community members are expected to join AIDS Healthcare Foundation (AHF) at a candlelight vigil and march to mark the 30th anniversary of the discovery of HIV. The "Remember AIDS" event—which will take place on Sunday, June 5th—will begin with a gathering at Matthew Shepard Memorial Park at 7:00 pm.
Inactivation of the MYC-associated factor X gene, MAX, may play a significant role in the development of small-cell lung cancer, scientists believe.
Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kaiser Shah, MD 1107 White Pine Ln, Western Springs, IL 60558-5018 Ph: (630) 802-8747 | Dr Kaiser Shah, MD 3333 Evergreen Dr Ne, Grand Rapids, MI 49525-9493 Ph: (616) 284-3132 |
News Archive
Misfiring of the brain's control system might underpin compulsions in obsessive-compulsive disorder (OCD), according to researchers at the University of Cambridge, writing in the American Journal of Psychiatry.
Hundreds of community members are expected to join AIDS Healthcare Foundation (AHF) at a candlelight vigil and march to mark the 30th anniversary of the discovery of HIV. The "Remember AIDS" event—which will take place on Sunday, June 5th—will begin with a gathering at Matthew Shepard Memorial Park at 7:00 pm.
Inactivation of the MYC-associated factor X gene, MAX, may play a significant role in the development of small-cell lung cancer, scientists believe.
Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today initial 12-month clinical data from its ongoing Phase 2 open-label extension (OLE) study with patisiran, an investigational RNAi therapeutic in development for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis) in patients with familial amyloidotic polyneuropathy (FAP).
› Verified 3 days ago
Matthew H Armstrong, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 | |
Daniel H. Robinson, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-5000 | |
Cheryl Lukins, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25 Michigan St Ne Ste 2200, Grand Rapids, MI 49503 Phone: 616-391-3245 | |
Dr. Jeffrey M Ricketts, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Christopher Ross Russo, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 710 Kenmoor Ave Se, Suite 200, Grand Rapids, MI 49546 Phone: 616-588-7246 Fax: 616-588-7086 | |
Samuel Lee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Michign St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 | |
Dr. Cindy Chu, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-5000 |